Fetal heart-rate variability response to uterine contractions during labour and delivery

Using cardiotocography data from labour and delivery, the objective of this study was to decompose fetal-heart rate variability (fHRV) based on auto-regressive power spectral density analysis into a quiescent component unrelated to contraction and a peak component response to contraction. During the last 3 hours of labour and delivery, this approach discriminated between normal and pathological fetuses in 15 of 18 epochs for the movement frequency (MF, 150-500 mHz) peak component and 11 of 18 epochs for the low frequency (LF, 30-150 mHz) peak component, and in all epochs of the quiescent components. These results were superior to previous results based on a longer time window that did not differentiate between contraction and non-contraction intervals. They are also very promising for the improved detection of fetal distress related to hypoxia.

[1]  S. Cerutti,et al.  Spectral analysis of antepartum heart rate variability. , 1989, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[2]  Maria Romano,et al.  Foetal heart rate power spectrum response to uterine contraction , 2006, Medical and Biological Engineering and Computing.

[3]  Doina Precup,et al.  Identification of the Dynamic Relationship Between Intrapartum Uterine Pressure and Fetal Heart Rate for Normal and Hypoxic Fetuses , 2009, IEEE Transactions on Biomedical Engineering.

[4]  David T. Westwick,et al.  Identification of nonlinear physiological systems , 2003 .

[5]  Doina Precup,et al.  Classification of Normal and Hypoxic Fetuses From Systems Modeling of Intrapartum Cardiotocography , 2010, IEEE Transactions on Biomedical Engineering.

[6]  Sergio Cerutti,et al.  Linear and nonlinear parameters for the analysisof fetal heart rate signal from cardiotocographic recordings , 2003, IEEE Transactions on Biomedical Engineering.